SETDB2 and neoplasm: The histone modifier SETDB2 was found to modulate adaptative resistance mechanisms in tumor development and in macrophage plasticity in inflammatory processes by regulating genomic stability and/or H3K9me3-mediated silencing of gene transcription [39, 40].